"More Americans than ever are developing kidney stones, and the demographics of those at increased risk are changing, a study published online January 14 in the Clinical Journal of the American Society of Nephrology has shown.
Renacidin is contraindicated in the presence of demonstrable urinary tract extravasation.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 11/12/2015
Additional Renacidin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.